Found: 17
Select item for more details and to access through your institution.
Evaluation of N-Desmethylclozapine as a Potential Antipsychotic—Preclinical Studies.
- Published in:
- Neuropsychopharmacology, 2007, v. 32, n. 7, p. 1540, doi. 10.1038/sj.npp.1301279
- By:
- Publication type:
- Article
Dissociation between In Vivo Occupancy and Functional Antagonism of Dopamine D<sub>2</sub> Receptors: Comparing Aripiprazole to Other Antipsychotics in Animal Models.
- Published in:
- Neuropsychopharmacology, 2006, v. 31, n. 9, p. 1854, doi. 10.1038/sj.npp.1300983
- By:
- Publication type:
- Article
Mitochondrial complex I density is associated with IQ and cognition in cognitively healthy adults: an in vivo [<sup>18</sup>F]BCPP-EF PET study.
- Published in:
- EJNMMI Research, 2024, v. 14, n. 1, p. 1, doi. 10.1186/s13550-024-01099-1
- By:
- Publication type:
- Article
The antipsychotic potential of l-stepholidine—a naturally occurring dopamine receptor D<sub>1</sub> agonist and D<sub>2</sub> antagonist.
- Published in:
- Psychopharmacology, 2008, v. 199, n. 2, p. 275, doi. 10.1007/s00213-008-1172-1
- By:
- Publication type:
- Article
Phosphodiesterase 10A PET Radioligand Development Program: From Pig to Human.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 4, p. 595, doi. 10.2967/jnumed.113.131409
- By:
- Publication type:
- Article
Evaluation of Intraperitoneal [ 18 F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity.
- Published in:
- Molecular Imaging, 2024, p. 1, doi. 10.1155/2022/4419221
- By:
- Publication type:
- Article
Evaluation of Intraperitoneal [ 18 F]-FDOPA Administration for Micro-PET Imaging in Mice and Assessment of the Effect of Subchronic Ketamine Dosing on Dopamine Synthesis Capacity.
- Published in:
- Molecular Imaging, 2022, v. 2022, p. 1, doi. 10.1155/2022/4419221
- By:
- Publication type:
- Article
Partial agonists in schizophrenia – why some work and others do not: insights from preclinical animal models.
- Published in:
- International Journal of Neuropsychopharmacology, 2011, v. 14, n. 9, p. 1165, doi. 10.1017/S1461145710001343
- By:
- Publication type:
- Article
A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse.
- Published in:
- Schizophrenia Bulletin, 2021, v. 47, n. 4, p. 1116, doi. 10.1093/schbul/sbab017
- By:
- Publication type:
- Article
SYNAPTIC MARKER PROTEIN SV2A IS REDUCED IN SCHIZOPHRENIA IN VIVO AND UNAFFECTED BY ANTIPSYCHOTICS IN RATS.
- Published in:
- Schizophrenia Bulletin, 2020, v. 46, p. S28, doi. 10.1093/schbul/sbaa028.063
- By:
- Publication type:
- Article
Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-019-14122-0
- By:
- Publication type:
- Article
Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Radiosynthesis, ex vivo and in vivo evaluation of [<sup>11</sup>C]preclamol as a partial dopamine D2 agonist radioligand for positron emission tomography.
- Published in:
- Synapse, 2006, v. 60, n. 4, p. 314, doi. 10.1002/syn.20304
- By:
- Publication type:
- Article
Correction: Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Sub-Chronic Ketamine Administration Increases Dopamine Synthesis Capacity in the Mouse Midbrain: a Preclinical In Vivo PET Study.
- Published in:
- Molecular Imaging & Biology, 2023, v. 25, n. 6, p. 1054, doi. 10.1007/s11307-023-01865-y
- By:
- Publication type:
- Article
Adenosine A<sub>2A</sub> receptor in schizophrenia: an in vivo brain PET imaging study.
- Published in:
- Psychopharmacology, 2022, v. 239, n. 11, p. 3439, doi. 10.1007/s00213-021-05900-0
- By:
- Publication type:
- Article